Literature DB >> 21160525

The molecular biology of head and neck cancer.

C René Leemans1, Boudewijn J M Braakhuis, Ruud H Brakenhoff.   

Abstract

Head and neck squamous cell carcinomas (HNSCCs) are caused by tobacco and alcohol consumption and by infection with high-risk types of human papillomavirus (HPV). Tumours often develop within preneoplastic fields of genetically altered cells. The persistence of these fields after treatment presents a major challenge, because it might lead to local recurrences and second primary tumours that are responsible for a large proportion of deaths. Aberrant signalling pathways have been identified in HNSCCs and inhibition of epidermal growth factor receptor (EGFR) has proved a successful therapeutic strategy. In this Review, we discuss the recent literature on tumour heterogeneity, field cancerization, molecular pathogenesis and the underlying causative cancer genes that can be exploited for novel and personalized treatments of patients with HNSCC.

Entities:  

Mesh:

Year:  2010        PMID: 21160525     DOI: 10.1038/nrc2982

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  150 in total

Review 1.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

2.  Multicentric origin of intraoral carcinoma.

Authors:  D P SLAUGHTER
Journal:  Surgery       Date:  1946-07       Impact factor: 3.982

3.  Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma.

Authors:  Antoine M Snijders; Brian L Schmidt; Jane Fridlyand; Nusi Dekker; Daniel Pinkel; Richard C K Jordan; Donna G Albertson
Journal:  Oncogene       Date:  2005-06-16       Impact factor: 9.867

Review 4.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

5.  Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.

Authors:  John C Sok; Francesca M Coppelli; Sufi M Thomas; Miriam N Lango; Sichuan Xi; Jennifer L Hunt; Maria L Freilino; Michael W Graner; Carol J Wikstrand; Darell D Bigner; William E Gooding; Frank B Furnari; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2006-09-01       Impact factor: 12.531

6.  A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization.

Authors:  M Partridge; S Pateromichelakis; E Phillips; G G Emilion; R P A'Hern; J D Langdon
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

7.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.

Authors:  E Schuuring; E Verhoeven; W J Mooi; R J Michalides
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867

8.  Frequent p53 mutations in head and neck cancer.

Authors:  K D Somers; M A Merrick; M E Lopez; L S Incognito; G L Schechter; G Casey
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

Review 9.  Showering c-MET-dependent cancers with drugs.

Authors:  Beatrice S Knudsen; George Vande Woude
Journal:  Curr Opin Genet Dev       Date:  2008-04-09       Impact factor: 5.578

10.  Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis.

Authors:  Serge J Smeets; Ruud H Brakenhoff; Bauke Ylstra; Wessel N van Wieringen; Mark A van de Wiel; C René Leemans; Boudewijn J M Braakhuis
Journal:  Cell Oncol       Date:  2009       Impact factor: 6.730

View more
  989 in total

Review 1.  Biomarkers predicting malignant progression of laryngeal epithelial precursor lesions: a systematic review.

Authors:  Juan P Rodrigo; Juana María García-Pedrero; Carlos Suárez; Robert P Takes; Lester D R Thompson; Pieter J Slootweg; Julia A Woolgar; William H Westra; Ruud H Brakenhoff; Alessandra Rinaldo; Kenneth O Devaney; Michelle D Williams; Douglas R Gnepp; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-12       Impact factor: 2.503

Review 2.  [Update on HPV-induced oropharyngeal cancer].

Authors:  S F Preuss; J-P Klussmann; R Semrau; C Huebbers
Journal:  HNO       Date:  2011-10       Impact factor: 1.284

3.  Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.

Authors:  Pratima Tripathi; Pachiyappan Kamarajan; Bagganahalli S Somashekar; Neil MacKinnon; Arul M Chinnaiyan; Yvonne L Kapila; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  Int J Biochem Cell Biol       Date:  2012-06-26       Impact factor: 5.085

4.  Presence of tumour high-endothelial venules is an independent positive prognostic factor and stratifies patients with advanced-stage oral squamous cell carcinoma.

Authors:  Anna M Wirsing; Oddveig G Rikardsen; Sonja E Steigen; Lars Uhlin-Hansen; Elin Hadler-Olsen
Journal:  Tumour Biol       Date:  2015-09-17

5.  EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression.

Authors:  Xianglan Zhang; Im-Hee Jung; Young Sun Hwang
Journal:  Tumour Biol       Date:  2015-09-19

6.  Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.

Authors:  Xu Qian; Steffen Wagner; Chenming Ma; Annekatrin Coordes; Julia Gekeler; Jens P Klussmann; Michael Hummel; Andreas M Kaufmann; Andreas E Albers
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-27       Impact factor: 4.553

7.  Bioluminescent imaging of HPV-positive oral tumor growth and its response to image-guided radiotherapy.

Authors:  Rong Zhong; Matt Pytynia; Charles Pelizzari; Michael Spiotto
Journal:  Cancer Res       Date:  2014-02-13       Impact factor: 12.701

8.  Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas.

Authors:  Daniel Schramek; Ataman Sendoel; Jeremy P Segal; Slobodan Beronja; Evan Heller; Daniel Oristian; Boris Reva; Elaine Fuchs
Journal:  Science       Date:  2014-01-17       Impact factor: 47.728

9.  Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes.

Authors:  Andrew M Overmiller; Jennifer A Pierluissi; Peter J Wermuth; Sami Sauma; Ubaldo Martinez-Outschoorn; Madalina Tuluc; Adam Luginbuhl; Joseph Curry; Larry A Harshyne; James K Wahl; Andrew P South; Mỹ G Mahoney
Journal:  FASEB J       Date:  2017-04-24       Impact factor: 5.191

10.  Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.

Authors:  Jinke Xu; Wei Lu; Senlin Zhang; Chuchao Zhu; Tingting Ren; Tong Zhu; Hu Zhao; Yanpu Liu; Jin Su
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.